NewAmsterdam Pharma Company NAMS
Last Price
52 Week Range
$14.06 - $42.00
Next Earnings Date
Feb 25 2026 (Estimate)
Next Earnings Date
Feb 25 2026 (Est.)
Last Price
NAMS Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
NewAmsterdam Pharma Company N.V. | 10-Q | November 5, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | November 5, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | September 2, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | August 18, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | August 15, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | August 6, 2025 | |
NewAmsterdam Pharma Company N.V. | 10-Q | August 6, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | July 30, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | July 11, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | June 11, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | June 9, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | June 6, 2025 | |
NewAmsterdam Pharma Company N.V. | ARS | May 8, 2025 | |
NewAmsterdam Pharma Company N.V. | DEF 14A | May 8, 2025 | |
NewAmsterdam Pharma Company N.V. | 10-Q | May 8, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | May 8, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | May 7, 2025 | |
NewAmsterdam Pharma Company N.V. | PRE 14A | April 28, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | April 17, 2025 | |
NewAmsterdam Pharma Company N.V. | 10-K | February 26, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | February 26, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | January 10, 2025 | |
NewAmsterdam Pharma Company N.V. | 8-K | December 13, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | December 10, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | December 10, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | November 20, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | November 18, 2024 | |
NewAmsterdam Pharma Company N.V. | 10-Q | November 6, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | November 6, 2024 | |
NewAmsterdam Pharma Company N.V. | 8-K | October 18, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.